Form 4 for MRNA Moderna
Accepted 2026-06-03 16:16:01 ET · period of report 2026-06-01 · accession 0001682852-26-000111 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-03 16:16 | 2026-06-01 | MRNA | Hoge Stephen | Pres | M - OptEx | — | +9,282 | 1.49M | +0.6% | — |
| D | 2026-06-03 16:16 | 2026-06-01 | MRNA | Hoge Stephen | Pres | F - Tax | $47.19 | -4,488 | 1.48M | -0.3% | -$211.8K |
| D | 2026-06-03 16:16 | 2026-06-01 | MRNA | Hoge Stephen | Pres | M - OptEx | $0.00 | -9,282 | 102.1K | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-01 | M | A | 9,282 | — | 1,488,336 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2026-06-01 | F | D | 4,488 | $47.19 | 1,483,848 | D | — | — | (F2) Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. |
| 3 | Derivative | Restricted Stock Units | 2026-06-01 | M | D | 9,282 | $0.00 | 102,111 | D | — · — to — | 9,282 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F1) Restricted stock units convert into common stock on a one-for-one basis. (F4) 25% of the shares subject to this restricted stock unit award vested on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter. (F4) 25% of the shares subject to this restricted stock unit award vested on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |